Recent 8-K filings for RMTG

• August 25, 2026, 6:06 AM ET other material materiality 0.70 positive item 8.01item 7.01item 9.01

  RMTG Q1 revenue up 90% YoY, Q2 quadrupled; Argentina license, Cancun lab expansion

  Q1 2026 revenue up 90% YoY; Q2 revenue quadrupled YoY; 2025 total revenue $5.1M.

• May 21, 2025, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01

  RMTG Q1 sales up 67% to $1.35M; achieves operating profit of $134K

  Q1 2025 revenue $1.35M, a 67% increase over Q1 2024.

• November 19, 2024, 6:59 PM ET other material materiality 0.65 positive item 2.02item 9.01

  RMTG reports Q3 sales up 52% YoY, achieves operational profitability, gross margin 75%

  Sales rose 52% YoY to $986,308; gross profit margin reached 75% for Q3 2024.

• October 24, 2024, 7:59 PM ET other material materiality 0.25 neutral item 8.01

  Meso Numismatics changes name to Regenerative Medical Technology Group, ticker to RMTG

  Name change to Regenerative Medical Technology Group Inc. effective Oct. 21, 2024 after FINRA processing.

• May 23, 2024, 7:59 PM ET other material materiality 0.40 positive item 2.02item 9.01

  Meso Numismatics reports positive operating cash flow >$100k in Q1 2024; proceeding with name change to RMTG

  Name change to Regenerative Medical Technology Group Inc. pending FINRA market effective date.

• December 13, 2023, 6:59 PM ET other material materiality 0.70 neutral item 1.01item 3.02item 9.01 ◈ Material Agreements

  Meso Numismatics secures up to $10M equity financing from GHS Investments

  GHS will purchase shares at 80% of market price (90% after up-list); puts up to $700K each over 24 months.

• September 27, 2023, 7:59 PM ET other material materiality 0.60 negative item 4.01item 9.01 ◈ Auditor Changes

  Meso Numismatics dismisses auditor, engages new firm; material weakness in internal controls persists

  Dismissed L J Soldinger Associates as independent auditor on Sept 22, 2023.

• March 23, 2022, 7:59 PM ET M&A materiality 0.70 neutral item 2.01item 1.01item 3.02item 5.01item 5.02item 8.01item 9.01

  Meso Numismatics completes acquisition of Global Stem Cells Group; financials show $105K net loss

  Acquisition closed Aug 18, 2021: Meso Numismatics acquires GCSC for 1M Series AA pref, 8,974 Series DD pref, and $225K.

• December 2, 2021, 6:59 PM ET other material materiality 0.55 negative item 4.01item 9.01

  Meso Numismatics replaces auditor M&K CPAS with L J Soldinger; prior reports had going concern

  M&K CPAS resigned as independent auditor on Nov 30, 2021; L J Soldinger Associates engaged on Dec 1, 2021.

• August 19, 2021, 7:59 PM ET M&A materiality 0.70 positive item 1.01item 2.01item 3.02item 5.01item 5.02item 8.01item 9.01

  Meso Numismatics closes Global Stem Cells Group acquisition; renegotiates $10.5M financing

  Acquired all GCSC shares for 1M Series AA Preferred, 8,974 Series DD Preferred, and $225,000 cash.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.70 · Median 0.65 · Most common event other_material

5 positive 2 negative 3 neutral

source · RMTG on sec.gov